Multiple primary melanoma with the Meyerson phenomenon in a young patient

Melanoma and Skin Cancer

Bullous Pemphigoid-like Skin Lesions and Overt Eosinophilia in a Patient With Melanoma Treated With Nivolumab: Case Report and Review of the Literature

J Immunother.

Anastasopoulou A, Papaxoinis G, Diamantopoulos P, Christofidou E, Benopoulou O, Stratigos A, Gogas H

Melanoma and Skin Cancer

Simultaneous long-lasting regression of multiple nevi and melanoma metastases after ipilimumab therapy

Melanoma Res.

Plaquevent M, Greliak A, Pinard C, Duval-Modeste AB, Joly P

doi: 10.1097/CMR.

Melanoma and Skin Cancer

Rapid evolution of acute kidney injury after initial infusion of pembrolizumab in a melanoma patient concurrently treated with RAF/MEK inhibitors

Melanoma Res.

Thummalapalli R, Melms JC, Mier J, Izar B

doi: 10.1097/CMR.0000000000000646.

Melanoma and Skin Cancer

Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report

BMC Cancer.

Ozaki Y, Shindoh J, Miura Y, Nakajima H, Oki R, Uchiyama M, Masuda J, Kinowaki K, Kondoh C, Tanabe Y, Tanaka T, Haruta S, Ueno M, Kitano S, Fujii T, Udagawa H, Takano T

doi: 10.1186/s12885-017-3785-4.

Melanoma and Skin Cancer

Dermatomyositis in a patient undergoing nivolumab therapy for metastatic melanoma: a case report and review of the literature

Melanoma Res.

Kosche C, Stout M, Sosman J, Lukas RV, Choi JN

doi: 10.1097/CMR.0000000000000642.

Melanoma and Skin Cancer

Difficult to diagnose small cutaneous melanoma metastases mimicking angiomas: utility of dermoscopy

Int J Dermatol.

Mazzella C, Costa C, Cappello M, Scalvenzi M

doi: 10.1111/ijd.14128.

Melanoma and Skin Cancer

Hemophagocytic lymphohistiocytosis of a melanoma patient under BRAF/MEK-inhibitor therapy following anti-PD1 inhibitor treatment: a case report and review to the literature

Melanoma Res.

Dudda M, Mann C, Heinz J, Schmidgen I, Weid F, Kühn M, Saloga J, Grabbe S, Loquai C

doi: 10.1097/CMR.0000000000000703.Visit the original publication at ncbi.nlm.nih.gov

Melanoma and Skin Cancer

The successful use of pembrolizumab in a renal transplant recipient with metastatic melanoma

Melanoma Res.

Hanna DL, Law SJ, Merrick SA, Heptinstall L, Bass P, Dupont P, Sheri A

doi: 10.1097/CMR.0000000000000651.

Melanoma and Skin Cancer

Morphea following treatment with pembrolizumab for melanoma with metastatic lymph nodes: case report and review of literature

Melanoma Res.

Zafar FS, Richey P, Okereke U, Milhem M, Abid R, Powers JG, Swick B

doi: 10.1097/CMR.0000000000000713.Visit the original publication at ncbi.nlm.nih.gov

Related content

Bullous Pemphigoid-like Skin Lesions and Overt Eosinophilia in a Patient With Melanoma Treated With Nivolumab: Case Report and Review of the Literature

Simultaneous long-lasting regression of multiple nevi and melanoma metastases after ipilimumab therapy

Rapid evolution of acute kidney injury after initial infusion of pembrolizumab in a melanoma patient concurrently treated with RAF/MEK inhibitors

Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report

Dermatomyositis in a patient undergoing nivolumab therapy for metastatic melanoma: a case report and review of the literature

Difficult to diagnose small cutaneous melanoma metastases mimicking angiomas: utility of dermoscopy

Hemophagocytic lymphohistiocytosis of a melanoma patient under BRAF/MEK-inhibitor therapy following anti-PD1 inhibitor treatment: a case report and review to the literature

The successful use of pembrolizumab in a renal transplant recipient with metastatic melanoma

Morphea following treatment with pembrolizumab for melanoma with metastatic lymph nodes: case report and review of literature